These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 10418754

  • 1. Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia.
    Onyeji CO, Bui KQ, Owens RC, Nicolau DP, Quintiliani R, Nightingale CH.
    Int J Antimicrob Agents; 1999 Jul; 12(2):107-14. PubMed ID: 10418754
    [Abstract] [Full Text] [Related]

  • 2. Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios.
    Scaglione F, Mouton JW, Mattina R, Fraschini F.
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2749-55. PubMed ID: 12936969
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic effect of oral levofloxacin, ciprofloxacin, and ampicillin on experimental murine pneumonia caused by penicillin intermediate Streptococcus pneumoniae for which the minimum inhibitory concentrations of the quinolones are similar.
    Ishida Y, Kurosaka Y, Murakami Y, Otani T, Yamaguchi K.
    Chemotherapy; 1999 Sep; 45(3):183-91. PubMed ID: 10224340
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
    Entenza JM, Caldelari I, Glauser MP, Moreillon P.
    J Antimicrob Chemother; 1999 Dec; 44(6):775-86. PubMed ID: 10590278
    [Abstract] [Full Text] [Related]

  • 6. In vivo oral efficacy of levofloxacin for treatment of systemic Pseudomonas aeruginosa infections in a murine model of septicemia.
    Yagel SK, Barrett JF, Amaratunga DJ, Frosco MB.
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2894-7. PubMed ID: 9124863
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and pharmacodynamics of gemifloxacin versus levofloxacin in guinea pig pneumococcal pneumonia induced by strains with decreased ciprofloxacin susceptibility.
    García-Olmos M, Parra A, García-Calvo G, Ponte C, Giménez MJ, Aguilar L, Soriano F.
    Int J Antimicrob Agents; 2003 Jun; 21(6):568-73. PubMed ID: 12791471
    [Abstract] [Full Text] [Related]

  • 9. Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model.
    Hershberger E, Rybak MJ.
    Antimicrob Agents Chemother; 2000 Mar; 44(3):598-601. PubMed ID: 10681324
    [Abstract] [Full Text] [Related]

  • 10. In vitro characterization of fluoroquinolone concentration/MIC antimicrobial activity and resistance while simulating clinical pharmacokinetics of levofloxacin, ofloxacin, or ciprofloxacin against Streptococcus pneumoniae.
    Madaras-Kelly KJ, Demasters TA.
    Diagn Microbiol Infect Dis; 2000 Aug; 37(4):253-60. PubMed ID: 10974576
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae.
    Licata L, Smith CE, Goldschmidt RM, Barrett JF, Frosco M.
    Antimicrob Agents Chemother; 1997 May; 41(5):950-5. PubMed ID: 9145850
    [Abstract] [Full Text] [Related]

  • 12. Relative potential for selection of fluoroquinolone-resistant Streptococcus pneumoniae strains by levofloxacin: comparison with ciprofloxacin, sparfloxacin and ofloxacin.
    Drugeon HB, Juvin ME, Bryskier A.
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():55-9. PubMed ID: 10404339
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and levofloxacin with Streptococcus pneumoniae in an in vitro dynamic model.
    Firsov AA, Alferova IV, Smirnova MV, Lubenko IY, Portnoy YA, Zinner SH.
    Int J Antimicrob Agents; 2005 May; 25(5):409-13. PubMed ID: 15848296
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.